Jeremiah McDole, PhD, is the oncology segment manager at Bio-Rad Laboratories. He received his PhD in neuroimmunology from the University of Cincinnati and spent his postdoctoral years on a number of successful research projects in the immunology department at Washington University School of Medicine in St. Louis
Highly sensitive ddPCR-based liquid biopsies can detect residual cancer DNA, improving treatment decisions
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.